Skip to content

The effect of thyrophyte herbal composition on the weight of patients with primary hypothyroidism

Evaluation the effect of thyrophyte herbal composition on the weight of patients with primary hypothyroidism

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210101049909N1
Enrollment
80
Registered
2021-06-18
Start date
2021-07-06
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothyroidy. Ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere

Interventions

Intervention 1: Intervention group: They receive levothyroxine and herbal composition (nigella sativa, trachyspermum ammi, citrus aurantifolia) at a dose of 4.5 g daily in 6 capsules of 750 mg for 8 w

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age: 20 to 65 years Patients known to have primary hypothyroidism by an endocrinologist Hypothyroid patients with overweight or obesity whose weight has not been controlled with levothyroxine

Exclusion criteria

Exclusion criteria: Uncontrolled systemic diseases Any diet for weight loss during the study and 3 months before arrival Take a vitamin supplement at least three months before or during the study Patient dissatisfaction with continued cooperation Pregnancy Lactation

Design outcomes

Primary

MeasureTime frame
Weight. Timepoint: Before and after intervention. Method of measurement: To measure weight, calculate the ratio of weight in kilograms to height squared in meters (body mass index) and calculate the ratio of waist to hip in centimeters (WHR) using weight and tape meters.

Secondary

MeasureTime frame
Lipid profile. Timepoint: Before and after intervention. Method of measurement: By blood test in mg/dl.;Fasting blood sugar. Timepoint: Before and after intervention. Method of measurement: By blood test in mg/dl.;Thyroid hormone (TSH, FT4, T3). Timepoint: Before and after intervention. Method of measurement: By blood test in ng/dl.;Depression score on Beck Depression questionnaire. Timepoint: Before and after intervention. Method of measurement: Beck Depression questionnaire.;Quality of Life score on WHO Quality of Life Questionnaire. Timepoint: Before and after intervention. Method of measurement: WHO Quality of Life Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNajme Javidi

Mashhad University of Medical Sciences

javidin9711@mums.ac.ir+98 51 3884 8931

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026